ENTITY

Cellid (299660 KS)

23

Analysis

Health Care • South Korea

Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.

more

Refresh

Exchange Announcement • 19 Nov 2024 17:49

Material Management Information related to Judgment of Investment(IND Approval Determination)(íìë©´ìì¹ë£ë°±ì BVACE6E7ì ì 1/2aì ìììí ê³íì¹ì¸)

Exchange Announcement • 06 Nov 2024 13:41

Material Management Information related to Judgment of Investment(Study Results)(COVID19 ìë°© ë°±ì AdCLDCoV191 OMIì ì 1/2ì ìììí ê²°ê³¼)

Exchange Announcement • 13 Aug 2024 17:09

Response to Request for Inquired Disclosure (Significant Change in Stock Trading Activities) : Denial

Exchange Announcement • 12 Aug 2024 17:22

Request for Inquired Disclosure(Significant Change in Stock Trading Activities)

Exchange Announcement • 09 Aug 2024 16:12

Results of issuance(Voluntary Disclosure)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x